RITE3 Trademark

Trademark Overview


On Friday, August 30, 2024, a trademark application was filed for RITE3 with the United States Patent and Trademark Office. The USPTO has given the RITE3 trademark a serial number of 98727351. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 30, 2024. This trademark is owned by SEED Therapeutics US, Inc.. The RITE3 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, clinical trials; research and development of new products; pharmaceutical, scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases
rite3

General Information


Serial Number98727351
Word MarkRITE3
Filing DateFriday, August 30, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, August 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesdrug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, clinical trials; research and development of new products; pharmaceutical, scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEED Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events


Event DateEvent Description
Friday, August 30, 2024NEW APPLICATION ENTERED